Dan is an accomplished life science executive officer with more than 30 years of life science experience leading finance and operations for both venture-backed and publicly-held companies. Prior to co-founding Danforth Advisors, he was COO or CFO of a number of life science companies, including biotechnology, medical devices, life science tools and diagnostics entities.  From 1997-2002, he was CFO of Transkaryotic Therapies, Inc and participated in the launch of a drug to treat Fabry disease.

Dan holds a BS from The Wharton School, University of Pennsylvania, and a MBA from Harvard Business School.

Select Achievements

• Participated in 14 IPOs and multiple filings, two SPAC mergers and numerous private placements
• Participated in raising more than $2 billion through public and private financings
• Past President of the Association of Bioscience Financial Officers